Shree Ganesh Remedies Ltd.
Snapshot View

260.50 -7.60 ▼-2.8%

06 December 2022, 04:01:00 PM
Volume: 6,786

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ganeshremedies.com
Market Cap 312.78 Cr.
Enterprise Value(EV) 334.86 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 12.36 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 21.07 Trailing Twelve Months Ending 2022-09
Industry PE 35.17 Trailing Twelve Months Ending 2022-09
Book Value / Share 57.55 Trailing Twelve Months Ending 2022-09
Price to Book Value 4.53 Calculated using Price: 260.50
Dividend Yield 0.19 Period Ending 2022-03
No. of Shares Subscribed 1.20 Cr. 12,006,727 Shares
FaceValue 10
Company Profile
The company is as ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.83%
1 Week
+2.82%
1 Month
-1.23%
3 Month
+12.09%
6 Month
+1.01%
1 Year
-18.86%
2 Year
+97.29%
5 Year
+760.87%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 31.98 10.38 8.06 17.31 20.75 19.95 25.35 21.18 24.02
Return on Capital Employed (%) 43.08 16.15 12.42 26.15 27.68 27.04 32.63 27.51 32.47
Return on Assets (%) 23.85 8.56 7.01 14.34 16.52 16.20 20.56 17.29 19.47

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 12 13 14 17 29 34 42 50 62 69
Non Curr. Liab. 0 0 0 0 0 1 0 0 0 29
Curr. Liab. 3 2 2 4 7 7 10 10 15 13
Minority Int.
Equity & Liab. 15 15 16 21 36 41 52 61 77 111
Non Curr. Assets 5 5 5 5 7 16 17 23 32 66
Curr. Assets 10 10 11 17 28 26 35 38 45 45
Misc. Exp. not W/O
Total Assets 15 15 16 21 36 41 52 61 77 111

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 18 17 16 20 27 35 58 49 71 81
Other Income 1 0 0 0 2 1 4 2 4 3
Total Income 19 17 16 20 29 36 63 51 75 84
Total Expenditure -14 -14 -14 -16 -22 -27 -47 -35 -53 -61
PBIDT 5 3 2 5 7 10 15 16 21 23
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -2 -3 -3 -3
Taxation -2 -1 -1 -1 -2 -2 -3 -3 -5 -5
Exceptional Items
PAT 3 1 1 3 5 6 10 10 13 15
Adjusted EPS 22 9 7 18 4 5 8 8 11 12

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 -5 4 3 13
Cash Fr. Inv. -3 0 -3 -1 -12
Cash Fr. Finan. 8 0 0 -1 -2
Net Change 4 -5 1 2 0
Cash & Cash Eqvt 6 1 2 3 3

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 63.57 63.57 68.39 68.39 69.12 69.12 69.12 69.12 68.27
Public 36.43 36.43 31.61 31.61 30.88 30.88 30.88 30.88 31.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 28 Nov 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst /Institutional Investor Meetings
Fri, 25 Nov 2022
Disclosure Under Regulation 30 Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations 2015 - Execution Of Deed Of Assignment Cum Sale For Acquisition Of Assets.
Disclosure under Regulation 30 of SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 - execution of deed of assignment cum sale for acquisition of assets.
Mon, 21 Nov 2022
Related Party Transactions In Terms Of Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the disclosure of Related Party Transactions for the half year ended September 30 2022.

Technical Scans View Details >>

Tue, 06 Dec 2022
High Increase 3 Months High Increase 3 Months
High Increase 2 Years High Increase 2 Years
High Increase 5 Years High Increase 5 Years
Closing Near 200 SMA Closing Near 200 SMA
CCI Bearish CCI Bearish

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,035.00 -0.2%
Cipla Ltd. 89,552.87 1,109.60 -0.5%
Divi's Laboratories Ltd. 89,088.60 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. 72,830.48 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. 68,844.81 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. 54,679.25 1,615.60 -0.2%
Abbott India Ltd. 42,939.85 20,207.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 34.92 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 29.79 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.42 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.18 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.61 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 48.70 20,207.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 4.09 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 7.35 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.51 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.53 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.98 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 15.82 20,207.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 0.00 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,207.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 798.70 20,207.65 +0.7%

FAQ's On Shree Ganesh Remedies Ltd.

What is Shree Ganesh Remed. share price?

Can I buy Shree Ganesh Remed. shares now?

What is the Dividend Yield of Shree Ganesh Remed.?

What is the Market Cap of Shree Ganesh Remed.?

What are the key metrics to analyse Shree Ganesh Remed.?

What is the 52 Week High and Low of Shree Ganesh Remed.?

What is the trend of Shree Ganesh Remed. share price?